Locations

Locations


Infections: A serious and growing health issue

  • SID is common in patients with haematological malignancies such as chronic lymphocytic leukaemia or multiple myeloma.1
     
  • Novel oncological therapies and resulting increased long-term survival of patients make SID more prevalent than ever.1
    ​​​​​​​
  • For example, multiple myeloma patients have a 7-fold higher risk of developing bacterial infections and even a 10-fold increased risk for viral infections. Furthermore, up to 22% of deaths in these patients could be due to infections.2

Infections are a major cause of morbidity and mortality in haematological malignancies.2,3

References

  1. Sánchez-Ramón S, et al. Primary and Secondary Immunodeficiency Diseases in Oncohaematology: Warning Signs, Diagnosis, and Management. Front Immunol. 2019; 10: 586.
  2. Blimark C, et al. Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients. Haematologica. 2015; 100:107-13.
  3. Nosari A. Infectious complications in chronic lymphocytic leukemia. Mediterr J Hematol Infect Dis. 2012;4(1):e2012070.